1) 日本リウマチ学会.新基準使用時のRA鑑別疾患難易度別リスト(2016.11.14修正).https://www.ryumachi-jp.com/info/161114_table1.pdf(2023年12月15日アクセス)
2) Fauchais AL, Ouattara B, Gondran G, et al. Articular manifestations in primary Sjögren's syndrome:clinical significance and prognosis of 188 patients. Rheumatology (Oxford) 2010;49(6):1164-72.
3) Ramos-Casals M, Brito-Zerón P, Seror R, et al. EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements. Rheumatology (Oxford) 2015;54(12):2230-8.
4) Bird HA, Esselinckx W, Dixon AS, et al. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979;38(5):434-9.
5) Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. 2012 provisional classification criteria for polymyalgia rheumatica:a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis 2012;71(4):484-92.
6) Umetsu A, Shimizu T, Iwamoto N, et al. Paraneoplastic syndrome presenting with polymyalgia rheumatica-like accumulations on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Intern Med 2019;58(6):861-4.
7) Kawase M, Nakane K, Namiki S, et al. A case of localized prostate cancer associated with polymyalgia rheumatica with marked symptomatic improvement after robot-assisted radical prostatectomy. Case Rep Urol 2021;2021:8026883. doi:10.1155/2021/8026883.
8) Auzary C, Le Thi Huong D, Delarbre X, et al. Subacute bacterial endocarditis presenting as polymyalgia rheumatica or giant cell arteritis. Clin Exp Rheumatol 2006;24(2 suppl 41):S38-40.
9) De Socio GV, Mencacci A, Bini P, et al. Fusobacterium nucleatum endocarditis mimicking polymyalgia rheumatica. South Med J 2009;102(10):1082-4.
10) McCarty DJ, O'Duffy JD, Pearson L, et al. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA 1985;254(19):2763-7.
11) Karmacharya P, Donato AA, Aryal MR, et al. RS3PE revisited:a systematic review and meta-analysis of 331 cases. Clin Exp Rheumatol 2016;34(3):404-15.
12) Hamaguchi Y, Fujimoto M, Matsushita T, et al. Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies:heterogeneity within the syndrome. PLoS One 2013;8(4):e60442. doi:10.1371/journal.pone.0060442.
13) Lefèvre G, Meyer A, Launay D, et al. Seronegative polyarthritis revealing antisynthetase syndrome:a multicentre study of 40 patients. Rheumatology (Oxford) 2015;54(5):927-32.
14) Matsushita M, Tamura N, Ogasawara M, et al. The association of anti-aminoacyl-transfer ribonucleic acid synthetase antibodies in patients with rheumatoid arthritis and interstitial lung disease. Arch Rheumatol 2017;33(1):26-32.
15) Kaneko Y, Hanaoka H, Hirakata M, et al. Distinct arthropathies of the hands in patients with anti-aminoacyl tRNA synthetase antibodies:usefulness of autoantibody profiles in classifying patients. Rheumatology (Oxford) 2014;53(6):1120-4.